Zolmax logo

The Latest Headlines at Zolmax

Image about Patrick Mauro Investment Advisor INC. Makes New Investment in CME Group Inc. $CME

Patrick Mauro Investment Advisor INC. Makes New Investment in CME Group Inc. $CME

Patrick Mauro Investment Advisor INC. purchased a new position in CME Group Inc. (NASDAQ:CME – Free Report) in the second quarter, HoldingsChannel reports. The firm purchased 52,702 shares of the financial services provider’s... More of this article »
Image about Pinterest (NYSE:PINS) Director Gokul Rajaram Sells 1,050 Shares

Pinterest (NYSE:PINS) Director Gokul Rajaram Sells 1,050 Shares

Pinterest, Inc. (NYSE:PINS – Get Free Report) Director Gokul Rajaram sold 1,050 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $23.03, for... More of this article »
Image about Monetta Financial Services Inc. Invests $2.34 Million in Nucor Corporation $NUE

Monetta Financial Services Inc. Invests $2.34 Million in Nucor Corporation $NUE

Monetta Financial Services Inc. purchased a new stake in Nucor Corporation (NYSE:NUE – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 10,500 shares of the basic... More of this article »
Image about Main Street Financial Solutions LLC Takes $1.46 Million Position in Philip Morris International Inc. $PM

Main Street Financial Solutions LLC Takes $1.46 Million Position in Philip Morris International Inc. $PM

Main Street Financial Solutions LLC acquired a new stake in Philip Morris International Inc. (NYSE:PM – Free Report) during the second quarter, HoldingsChannel reports. The fund acquired 8,058 shares of the company’s stock,... More of this article »
Image about Teekay (NYSE:TK) CFO Brody Speers Sells 2,350 Shares of Stock

Teekay (NYSE:TK) CFO Brody Speers Sells 2,350 Shares of Stock

Teekay Corporation Ltd. (NYSE:TK – Get Free Report) CFO Brody Speers sold 2,350 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $13.10, for a total transaction of $30,785.00.... More of this article »
Image about MSH Capital Advisors LLC Takes Position in Realty Income Corporation $O

MSH Capital Advisors LLC Takes Position in Realty Income Corporation $O

MSH Capital Advisors LLC purchased a new position in Realty Income Corporation (NYSE:O – Free Report) during the 2nd quarter, HoldingsChannel reports. The fund purchased 59,864 shares of the real estate investment trust’s... More of this article »
Image about 10,887 Shares in CME Group Inc. $CME Bought by MSH Capital Advisors LLC

10,887 Shares in CME Group Inc. $CME Bought by MSH Capital Advisors LLC

MSH Capital Advisors LLC bought a new position in CME Group Inc. (NASDAQ:CME – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,887... More of this article »
Image about MSH Capital Advisors LLC Takes $1.55 Million Position in WEC Energy Group, Inc. $WEC

MSH Capital Advisors LLC Takes $1.55 Million Position in WEC Energy Group, Inc. $WEC

MSH Capital Advisors LLC purchased a new position in shares of WEC Energy Group, Inc. (NYSE:WEC – Free Report) in the 2nd quarter, Holdings Channel.com reports. The firm purchased 13,292 shares of the utilities provider’s... More of this article »
Image about Glj Research Reiterates “Hold” Rating for Fluence Energy (NASDAQ:FLNC)

Glj Research Reiterates “Hold” Rating for Fluence Energy (NASDAQ:FLNC)

Fluence Energy (NASDAQ:FLNC – Get Free Report)‘s stock had its “hold” rating reissued by Glj Research in a report issued on Thursday,Benzinga reports. They currently have a $12.89 target price on the stock,... More of this article »
Image about BTIG Research Boosts OrthoPediatrics (NASDAQ:KIDS) Price Target to $29.00

BTIG Research Boosts OrthoPediatrics (NASDAQ:KIDS) Price Target to $29.00

OrthoPediatrics (NASDAQ:KIDS – Get Free Report) had its price target lifted by investment analysts at BTIG Research from $24.00 to $29.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy”... More of this article »
Image about MSH Capital Advisors LLC Makes New Investment in Phillips 66 $PSX

MSH Capital Advisors LLC Makes New Investment in Phillips 66 $PSX

MSH Capital Advisors LLC purchased a new stake in Phillips 66 (NYSE:PSX – Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 3,250 shares of the oil and... More of this article »
Image about Cantor Fitzgerald Begins Coverage on Milestone Pharmaceuticals (NASDAQ:MIST)

Cantor Fitzgerald Begins Coverage on Milestone Pharmaceuticals (NASDAQ:MIST)

Equities researchers at Cantor Fitzgerald began coverage on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat reports. The firm set... More of this article »
Image about Cantor Fitzgerald Forecasts Strong Price Appreciation for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock

Cantor Fitzgerald Forecasts Strong Price Appreciation for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) had its price target lifted by equities research analysts at Cantor Fitzgerald from $96.00 to $103.00 in a research report issued to clients and investors on Thursday,Benzinga... More of this article »
Image about Korro Bio’s (KRRO) “Buy” Rating Reiterated at HC Wainwright

Korro Bio’s (KRRO) “Buy” Rating Reiterated at HC Wainwright

Korro Bio (NASDAQ:KRRO – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Thursday,Benzinga reports. They presently have a $15.00 price objective... More of this article »
Image about Craig Hallum Initiates Coverage on Quince Therapeutics (NASDAQ:QNCX)

Craig Hallum Initiates Coverage on Quince Therapeutics (NASDAQ:QNCX)

Investment analysts at Craig Hallum initiated coverage on shares of Quince Therapeutics (NASDAQ:QNCX – Get Free Report) in a note issued to investors on Thursday. The firm set a “buy” rating and a $68.00 price target... More of this article »